Myriad Genetics (MYGN) Other financing activities (2010 - 2025)
Myriad Genetics (MYGN) reported Other financing activities of -$8.6 million for Q4 2025, down 2050.0% year-over-year from $441025.6 in Q4 2024, and down 2050.0% quarter-over-quarter from -$400000.0 in Q4 2024.
Myriad Genetics (MYGN) Other financing activities (2010 - 2025) Analysis & Trends
Myriad Genetics (MYGN) has 15 years of Other financing activities data on file, last reported at -$8.6 million in Q4 2025.
- Other financing activities for Q4 2025 came in at -$8.6 million, down 2050.0% year-over-year; the trailing twelve-month figure through Dec 2025 was -$8.3 million (down 2866.67% YoY), and the FY2025 annual result was -$200000.0, up 50.0% from the prior year.
- Other financing activities retreated to -$8.6 million in Q4 2025 per MYGN's latest filing, from -$400000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $1.2 million in Q1 2021 and troughed at -$8.6 million in Q4 2025.
- A 4-year average of -$1.8 million and a median of $150000.0 in 2022 frame the typical range for Other financing activities.
- On a YoY basis, Other financing activities climbed as much as 2050.0% in 2025 and fell as far as 2050.0% in 2025.
- A 4-year view of Other financing activities shows it stood at $1.2 million in 2021, then plunged by 41.67% to $700000.0 in 2022, then sank by 157.14% to -$400000.0 in 2024, then slumped by 2050.0% to -$8.6 million in 2025.
- Business Quant data shows MYGN's Other financing activities at -$8.6 million in Q4 2025, -$400000.0 in Q4 2024, and $700000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | Myriad Genetics | 424.93 Mn | 300.53 Mn | 137.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.60 Mn |
| Dec 31, 2025 | -8.60 Mn |
| Dec 31, 2024 | -400,000.00 |
| Dec 31, 2024 | -400,000.00 |
| Sep 30, 2022 | 700,000.00 |
| Sep 30, 2022 | 700,000.00 |
| Mar 31, 2021 | 1.20 Mn |
| Mar 31, 2021 | 1.20 Mn |
| Sep 30, 2020 | 1.00 Mn |
| Sep 30, 2020 | 1.00 Mn |
| Jun 30, 2020 | 1.00 Mn |
| Jun 30, 2020 | 1.00 Mn |
| Dec 31, 2019 | 1.80 Mn |
| Dec 31, 2019 | 1.80 Mn |
| Sep 30, 2019 | -500,000.00 |
| Sep 30, 2019 | -500,000.00 |
| Jun 30, 2019 | 129.60 Mn |
| Jun 30, 2019 | 129.60 Mn |
| Mar 31, 2019 | 1.90 Mn |
| Mar 31, 2019 | 1.90 Mn |